CagriSema's rate of approximately 6% is comparable to semaglutide, reflecting its established semaglutide component
For patients with underlying health conditions (e.g., diabetes or heart conditions), it is essential to consult with a healthcare provider to determine which peptide would be most appropriate, as each may have different interactions with other medications or conditions
Its production requires solid-phase peptide synthesis (SPPS), which is expensive, slower to scale and more sensitive to impurity generation
The vendors most likely to continue selling tirzepatide are those with the highest risk tolerance, which does not always correlate with the highest quality standards
A saucepan full of water will create large amounts of steam or water vapor
Treatment with pioglitazone at 30 mg/day has led to statistically important improvement of inflammation in patients with NASH, with or without diabetes